1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Vasospastic Angina Global Clinical Trials Review, H2, 2016

Vasospastic Angina Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, “Vasospastic Angina Global Clinical Trials Review, H2, 2016" provides an overview of Vasospastic Angina clinical trials scenario. This report provides top line data relating to the clinical trials on Vasospastic Angina. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Vasospastic Angina Global Clinical Trials Review, H2, 2016
Table of Contents
Table of Contents 2


Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Countries Contributing to Clinical Trials in North America 9
Top Countries Contributing to Clinical Trials in Middle East and Africa 10
Clinical Trials by G7 Countries: Proportion of Vasospastic Angina to Cardiovascular Clinical Trials 11
Clinical Trials by Phase in G7 Countries 12
Clinical Trials by E7 Countries: Proportion of Vasospastic Angina to Cardiovascular Clinical Trials 13
Clinical Trials by Phase 14
Clinical Trials by Trial Status 15
Clinical Trials by End Point Status 16
Clinical Trials by Sponsor Type 17
Prominent Sponsors 18
Top Companies Participating in Vasospastic Angina Therapeutics Clinical Trials 19
Prominent Drugs 20
Clinical Trial Profile Snapshots 21
Appendix 31
Abbreviations 31
Definitions 31
Research Methodology 32
Secondary Research 32
About GlobalData 33
Contact Us 33
Disclaimer 33
Source 34

List of Tables
Vasospastic Angina Therapeutics, Global, Clinical Trials by Region, 2016* 5
Vasospastic Angina Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Vasospastic Angina Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Vasospastic Angina Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8
Vasospastic Angina Therapeutics Clinical Trials, North America, Top Countries, 2016* 9
Vasospastic Angina Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 10
Proportion of Vasospastic Angina to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 11
Vasospastic Angina Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 12
Proportion of Vasospastic Angina to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 13
Vasospastic Angina Therapeutics, Global, Clinical Trials by Phase, 2016* 14
Vasospastic Angina Therapeutics, Global, Clinical Trials by Trial Status, 2016* 15
Vasospastic Angina Therapeutics Clinical Trials, Global, by End Point Status, 2016* 16
Vasospastic Angina Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 17
Vasospastic Angina Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 18
Vasospastic Angina Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 19
Vasospastic Angina Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 20

List of Figures
Vasospastic Angina Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
Vasospastic Angina Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Vasospastic Angina Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Vasospastic Angina Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 8
Vasospastic Angina Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 9
Proportion of Vasospastic Angina to Cardiovascular Clinical Trials, G7 Countries (%), 2016* 11
Vasospastic Angina Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 12
Proportion of Vasospastic Angina to Cardiovascular Clinical Trials, E7 Countries (%), 2016* 13
Vasospastic Angina Therapeutics, Global, Clinical Trials by Phase (%), 2016* 14
Vasospastic Angina Therapeutics, Global, Clinical Trials by Trial Status, 2016* 15
Vasospastic Angina Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 17
Vasospastic Angina Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 18
Vasospastic Angina Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 19
Vasospastic Angina Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 20
GlobalData Methodology 32

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Chronic Stable Angina-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Chronic Stable Angina-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Chronic Stable Angina-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Angina (Angina Pectoris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Angina (Angina Pectoris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Angina (Angina Pectoris)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

 Chronic Stable Angina-Pipeline Insights, 2016

Chronic Stable Angina-Pipeline Insights, 2016

  • $ 1250
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “ Chronic Stable Angina-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Chronic Stable Angina. The ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.